SCHEDULE: Bigger Capital, District 2 Boost ClearPoint Neuro Stake
Beneficial Ownership Disclosure
Investment funds Bigger Capital and District 2, along with Michael Bigger, disclose increased passive beneficial ownership in ClearPoint Neuro, Inc., with Michael Bigger now holding 7.6%.
Summary
- Bigger Capital Fund L P and Bigger Capital Fund GP, LLC each beneficially own 1,292,372 shares, representing approximately 4.55% of ClearPoint Neuro, Inc.'s common stock.
- District 2 Capital Fund LP, District 2 Capital LP, District 2 GP LLC, and District 2 Holdings LLC each beneficially own 307,753 shares, representing approximately 1.1% of the common stock.
- Michael Bigger, through various entities and personal holdings, beneficially owns an aggregate of 2,145,817 shares, equating to approximately 7.6% of the outstanding common stock.
- Patricia Winter beneficially owns 167,000 shares, representing 0% of the outstanding common stock.
- The percentages are based on 28,423,308 shares of Common Stock outstanding as of October 7, 2025, as reported in ClearPoint Neuro, Inc.'s Form 10-Q filed on November 6, 2025.
- The investment is certified as passive, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: This is a neutral, factual disclosure of beneficial ownership. While increased institutional ownership can be seen as positive, the filing itself contains no qualitative information to assess sentiment beyond the fact of ownership.
Positives
- Increased beneficial ownership by institutional investors (Bigger Capital and District 2) and a significant individual investor (Michael Bigger) may signal confidence in ClearPoint Neuro, Inc.
- Michael Bigger's aggregate beneficial ownership of 7.6% makes him a substantial shareholder.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Increased institutional ownership by Bigger Capital and District 2, and a significant individual stake by Michael Bigger, could be viewed positively as a vote of confidence in the company.
- Company Management: Awareness of a significant passive shareholder group.
Key Dates
| Date | Description |
|---|---|
| 2025-09-30 | Date of event requiring the filing of this statement (crossing the 5% beneficial ownership threshold). |
| 2025-10-07 | Date for total shares outstanding (28,423,308) as reported in Issuer's Form 10-Q. |
| 2025-11-06 | Date Issuer's Form 10-Q was filed with the SEC. |
| 2025-11-11 | Date as of which beneficial ownership amounts were calculated. |
| 2025-11-12 | Date the Schedule 13G was signed. |
Keywords
ClearPoint Neuro, beneficial ownership, Schedule 13G, institutional investment, passive investment, Bigger Capital, District 2 Capital, Michael Bigger, medical device, neuroscience
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.